Unbiased Analysis of Today's Healthcare Issues
What role should digital therapeutics (DTx) play in our treatment landscape? What regulatory and access processes need to be established to be sure these treatments are safe, effective and high value? What evidence is needed to support claims of safety, efficacy and value? These questions and more were tackled as part of an AMCP Partnership…
If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “The Cost of Adherence Mismeasurement: A Claims-Based Analysis” co-authored with Felicia Forma, Ethan Scherer, Ainslie Hatch and Darius Lakdawalla. The presentation abstract is below and here. BACKGROUND: Payers often wish to measure how adherence to prescription drugs affects downstream…
If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “Adherence Patterns for Oral Atypical Antipsychotics in Patients Diagnosed with Schizophrenia” co-authored with Joanna MacEwan, Felicia Forma, Ainslie Hatch and Darius Lakdawalla. The presentation abstract is below and here. BACKGROUND: Many payers rely on claims-based metrics—such as those…
Next month in San Diego, the Academy of Managed Care Pharmacy is holding its annual conference. I am a co-author on two abstracts accepted as part of the conference. The first abstract won a platinum medal as one of the top 7 abstracts in the entire conference, the second abstract won a silver medal as well. The titles…